Hepatic cytochrome P450 regulation in disease states.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Current drug metabolism

• Publication date

  2001-05-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/1389200013338676PMID 11469724
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction and suppression of renal and hepatic cytochrome P450-dependent monooxygenases by acute and chronic streptozotocin diabetes in hamsters

  2009cited by this paper
• Depression of drug metabolizing activity in the human liver by interferon-α

  2004cited by this paper
• Pharmacokinetics of caffeine in patients with decompensated type I and type II diabetes mellitus

  2004cited by this paper
• Insulin-mimetic effects of vanadate in preventing the increase of P450IIIA and P450IA subfamily proteins in streptozotocin-diabetic rats

  2004cited by this paper
• Regulation of cytochrome p450 by inflammatory mediators: why and how?

  2001cited by this paper
• Regulation of hepatic cytochrome P450 2C11 via cAMP: implications for down-regulation in diabetes, fasting, and inflammation.

  2001cited by this paper
• Characterization of CYP4A induction in rat liver by inflammatory stimuli: dependence on sex, strain, and inflammation-evoked hypophagia.

  2001cited by this paper
• Hepatic and central nervous system cytochrome P450 are down-regulated during lipopolysaccharide-evoked localized inflammation in brain.

  2000cited by this paper
• Suppression of CYP2C11 gene transcription by interleukin-1 mediated by NF-kappaB binding at the transcription start site.

  2000cited by this paper
• Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes.

  2000cited by this paper
• Evaluation of the Influence of Diabetes Mellitus on Antipyrine Metabolism and CYP1A2 and CYP2D6 Activity

  2000cited by this paper
• Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR.

  2000cited by this paper
• The Peroxisome Proliferator Response Element of the Gene Encoding the Peroxisomal β-Oxidation Enzyme Enoyl-CoA Hydratase/3-Hydroxyacyl-CoA Dehydrogenase Is a Target for Constitutive Androstane Receptor β/9-cis-Retinoic Acid Receptor-mediated Transactivation*

  2000cited by this paper
• The PAS superfamily: sensors of environmental and developmental signals.

  2000cited by this paper
• Signaling pathways in insulin action: molecular targets of insulin resistance.

  2000cited by this paper
• Hepatic cytochrome P450 down‐regulation during aseptic inflammation in the mouse is interleukin 6 dependent

  2000cited by this paper
• Humanized xenobiotic response in mice expressing nuclear receptor SXR

  2000cited by this paper
• Hepatic drug metabolism and immunostimulation.

  2000cited by this paper
• Constitutive and inducible expression of hepatic CYP2E1 in leptin-deficient ob/ob mice.

  2000cited by this paper
• The Coactivator PGC-1 Cooperates with Peroxisome Proliferator-Activated Receptor α in Transcriptional Control of Nuclear Genes Encoding Mitochondrial Fatty Acid Oxidation Enzymes

  2000cited by this paper
• P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR.

  1999cited by this paper
• Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent.

  1999cited by this paper
• Characterization of cytochrome P450 and glutathione S-transferase activity and expression in male and female ob/ob mice

  1999cited by this paper
• The role of phosphatidylinositol 3-kinase, Src kinase, and protein kinase A signaling pathways in insulin and glucagon regulation of CYP2E1 expression.

  1999cited by this paper
• Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats.

  1999cited by this paper
• Hepatic cytochrome P-450 expression in tumor necrosis factor-alpha receptor (p55/p75) knockout mice after endotoxin administration.

  1999cited by this paper
• Effect of leptin on cytochrome P-450, conjugation, and antioxidant enzymes in the ob/ob mouse.

  1999cited by this paper
• Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans.

  1999cited by this paper
• The roles of cytochrome P450 3A4 and lA2 in the 3‐hydroxylation of quinine in vivo

  1999cited by this paper
• Effects of obesity on the cytochrome P450 enzyme system.

  1999cited by this paper
• Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity.

  1999cited by this paper
• The Repressed Nuclear Receptor CAR Responds to Phenobarbital in Activating the Human CYP2B6 Gene*

  1999cited by this paper
• Molecular mechanisms of cytochrome P-450 induction by xenobiotics: An expanded role for nuclear hormone receptors.

  1999cited by this paper
• Hepatic cytochrome P450 is directly inactivated by nitric oxide, not by inflammatory cytokines, in the early phase of endotoxemia.

  1999cited by this paper
• Interleukin-2 overexpresses c-myc and down-regulates cytochrome P-450 in rat hepatocytes.

  1999cited by this paper
• STAT5b Down-regulates Peroxisome Proliferator-activated Receptor α Transcription by Inhibition of Ligand-independent Activation Function Region-1trans-Activation Domain*

  1999cited by this paper
• Hepatic Drug Metabolism in Critical Illness

  1998cited by this paper
• Oncostatin M down-regulates basal and induced cytochromes P450 in human hepatocytes.

  1998cited by this paper
• Leptin and the regulation of body weight in mammals

  1998cited by this paper
• Peroxynitrite-mediated nitration of tyrosine and inactivation of the catalytic activity of cytochrome P450 2B1.

  1998cited by this paper
• Peroxisome proliferator activated receptor-alpha expression in human liver.

  1998cited by this paper
• Regulation of rabbit cytochrome P450 2E1 expression in HepG2 cells by insulin and thyroid hormone.

  1998cited by this paper
• Xenobiotic-enhanced expression of cytochromes P450 2E1 and 2B in primary cultured rat hepatocytes.

  1998cited by this paper
• Differential inducibility of specific mRNA corresponding to five CYP3A isoforms in female rat liver by RU486 and food deprivation: comparison with protein abundance and enzymic activities.

  1998cited by this paper
• Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation

  1998cited by this paper
• Altered Cell Surface Expression and Signaling of Leptin Receptors Containing the fatty Mutation*

  1998cited by this paper
• Differential alterations in levels of hepatic microsomal cytochrome P450 isozymes following intracerebroventricular injection of bacterial lipopolysaccharide in rats

  1998cited by this paper
• Peroxisome Proliferator-activated Receptor α Controls the Hepatic CYP4A Induction Adaptive Response to Starvation and Diabetes*

  1998cited by this paper
• Comparative effects of cytokines on constitutive and inducible expression of the gene encoding for the cytochrome P450 3A6 isoenzyme in cultured rabbit hepatocytes: consequences on progesterone 6beta-hydroxylation.

  1998cited by this paper
• Down-regulation of Cytochrome P450 1A1 Gene Promoter by Oxidative Stress

  1998cited by this paper
• Down-regulation of the expression of three major rat liver cytochrome P450S by endotoxin in vivo occurs independently of nitric oxide production.

  1998cited by this paper
• Down-regulation of cytochrome P450 mRNAs and proteins in mice lacking a functional NOS2 gene.

  1998cited by this paper
• A genetic polymorphism in the regulatory sequences of human CYP2E1: association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake.

  1998cited by this paper
• Endotoxin depresses hepatic cytochrome P450-mediated drug metabolism in women.

  1997cited by this paper
• Nitric oxide-mediated inhibition of cytochrome P450 by interferon-gamma in human hepatocytes.

  1997cited by this paper
• Nitric oxide-independent suppression of P450 2C11 expression by interleukin-1beta and endotoxin in primary rat hepatocytes.

  1997cited by this paper
• Effect of transforming growth factor-beta1 on expression of aryl hydrocarbon receptor and genes of Ah gene battery: clues for independent down-regulation in A549 cells.

  1997cited by this paper
• Inhibition of rat and human cytochrome P4502E1 catalytic activity and reactive oxygen radical formation by nitric oxide.

  1997cited by this paper
• Differential effects of interleukin-1 beta, interleukin-2, and interferon-gamma on the inducible expression of CYP 1A1 and CYP 1A2 in cultured rabbit hepatocytes.

  1997cited by this paper
• Evidence for nitric oxide participation in down-regulation of CYP2B1/2 gene expression at the pretranslational level.

  1997cited by this paper
• Irreversible inhibition of cytochrome P450 by nitric oxide.

  1997cited by this paper
• Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

  1997cited by this paper
• Effects of fatty acids and ketone bodies on cytochromes P450 2B, 4A, and 2E1 expression in primary cultured rat hepatocytes.

  1997cited by this paper
• Insulin effects on CYP2E1, 2B, 3A, and 4A expression in primary cultured rat hepatocytes.

  1997cited by this paper
• Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma.

  1997cited by this paper
• Differential inductive and suppressive effects of endotoxin and particulate irritants on hepatic and renal cytochrome P-450 expression.

  1997cited by this paper
• Nitric oxide differentially affects constitutive cytochrome P450 isoforms in rat liver.

  1997cited by this paper
• Regulation of cytochromes P450 during inflammation and infection.

  1997cited by this paper
• Regulation of CYP4A1 and peroxisome proliferator-activated receptor alpha expression by interleukin-1beta, interleukin-6, and dexamethasone in cultured fetal rat hepatocytes.

  1997cited by this paper
• Suppression of cytochrome P450- and UDP glucuronosyl transferase-dependent enzyme activities by proinflammatory cytokines and possible role of nitric oxide in primary cultures of pig hepatocytes.

  1996cited by this paper
• Role of nitric oxide in the cytokine-mediated regulation of cytochrome P-450.

  1996cited by this paper
• Interaction of nitrogen monoxide with cytochrome P-450 monitored by surface-enhanced resonance Raman scattering.

  1996cited by this paper
• Nitric Oxide Mediates Hepatic Cytochrome P450 Dysfunction Induced by Endotoxin

  1996cited by this paper
• Loss and Degradation of Enzyme-bound Heme Induced by Cellular Nitric Oxide Synthesis (*)

  1995cited by this paper
• Inhibition of P450 cytochromes by reactive intermediates.

  1995cited by this paper
• Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture

  1995cited by this paper
• Defective expression of cytochrome P450 proteins in the liver of the genetically obese Zucker rat.

  1995cited by this paper
• Theophylline metabolism in healthy nonsmokers and in patients with insulin‐dependent diabetes mellitus

  1995cited by this paper
• Insulin down-regulates cytochrome P450 2B and 2E expression at the post-transcriptional level in the rat hepatoma cell line.

  1995cited by this paper
• Expression of the CYP3A and CYP2C11 enzymes in a nutritionally obese rodent model: response to phenobarbital treatment.

  1994cited by this paper
• Cytochrome P450 changes in rats with streptozocin-induced diabetes.

  1994cited by this paper
• Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism.

  1994cited by this paper
• The pharmacokinetics and pharmacodynamics of quinine in the diabetic and non-diabetic elderly.

  1994cited by this paper
• Inhibition of cytochromes P4501A by nitric oxide.

  1994cited by this paper
• Transforming growth factor-beta 1 down-regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult human hepatocytes in primary culture.

  1994cited by this paper
• Modulation of the rat hepatic cytochrome P450 composition by long-term streptozotocin-induced insulin-dependent diabetes.

  1994cited by this paper
• Cytochrome P450 2B enzyme (CYP2B) induction defect following phenobarbital treatment in the fa/fa Zucker rat: molecular characterization.

  1993cited by this paper
• Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetes.

  1993cited by this paper
• Pretranslational induction of CYP4A subfamily gene products in diabetic rats and reversal by oral vanadate treatment.

  1993cited by this paper
• Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent.

  1993cited by this paper
• Interferon suppresses erythromycin metabolism in rats and human subjects

  1993cited by this paper
• Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants.

  1993cited by this paper
• Depression of Drug‐metabolizing Activity in the Human Liver by Interferon‐β

  1993cited by this paper
• Effects of interferon-alpha monotherapy on hepatic drug metabolism in cancer patients.

  1993cited by this paper
• Expression of a male-specific cytochrome P450 isozyme (CYP2C11) in fa/fa Zucker rats: effect of phenobarbital treatment.

  1993cited by this paper
• Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture.

  1993cited by this paper
• Induction of rat hepatic mixed-function oxidases by acetone and other physiological ketones: their role in diabetes-induced changes in cytochrome P450 proteins.

  1992cited by this paper
• Cytochrome P-450-dependent mixed-function oxidase and glutathione S-transferase activities in spontaneous obesity-diabetes.

  1992cited by this paper
• Growth hormone-dependent and -independent regulation of cytochrome P-450 isozyme expression in streptozotocin-diabetic rats.

  1991cited by this paper
• The Effects of Diabetes Mellitus on Pharmacokinetics and Pharmacodynamics in Humans

  1991cited by this paper

• Explaining clinically important variability in response to simvastatin treatment using a PBPK/PD approach

  2026cites this paper
• Exploring the roles of cytochrome P450 enzymes and their inhibitors in cancers and non-neoplastic human diseases

  2025cites this paper
• Redefining Statin Dosage Post‐Gastric Bypass: Insights from a Population Pharmacokinetics–Pharmacodynamics Link Approach

  2024cites this paper
• EIDD-1931 Treatment Tweaks CYP3A4 and CYP2C8 in Arthritic Rats to Expedite Drug Interaction: Implication in Oral Therapy of Molnupiravir

  2024cites this paper
• A novel near-infrared chemodosimeter to monitor the change of carboxylesterase in treatment of diabetes

  2023cites this paper
• Evaluation of the impact of vindoline, an active components of Catharanthus roseus, on rat hepatic cytochrome P450 enzymes by using a cocktail of probe drugs

  2023cites this paper
• Pharmacokinetics of obese adults: Not only an increase in weight.

  2023cites this paper
• Slower Recovery with Early Lopinavir/Ritonavir use in Pediatric COVID-19 Patients: A Retrospective Observational Study

  2022cites this paper
• Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper

  2021cites this paper
• Potential Effects of COVID-19 on Cytochrome P450-Mediated Drug Metabolism and Disposition in Infected Patients

  2021cites this paper
• Pharmacodynamic and pharmacokinetic interaction of losartan with glimepiride-metformin combination in rats and rabbits

  2021cites this paper
• Pharmacogenomics of ketamine: A systematic review.

  2021cites this paper
• Oleuropein-Induced Acceleration of Cytochrome P450–Catalyzed Drug Metabolism: Central Role for Nuclear Receptor Peroxisome Proliferator-Activated Receptor α

  2021influential citation
• Pharmacokinetics of omeprazole in rats with dextran sulfate sodium-induced ulcerative colitis.

  2020cites this paper
• Psychotropes et sujet âgé

  2020cites this paper
• Population pharmacokinetics of gabapentin in patients with neuropathic pain: Lack of effect of diabetes or glycaemic control

  2020cites this paper
• Use of 4β‐Hydroxycholesterol Plasma Concentrations as an Endogenous Biomarker of CYP3A Activity: Clinical Validation in Individuals With Type 2 Diabetes

  2019cites this paper
• Towards safer drug therapy and improved clinical outcomes in elderly and multimorbid patients

  2019cites this paper
• Prevalence and risk factors of drug-related hospitalizations in multimorbid patients admitted to an internal medicine ward

  2019cites this paper
• Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL)

  2018cites this paper
• Odeurs indésirables de la viande de porcs mâles non castrés : problèmes et solutions potentielles

  2018cites this paper
• Alterations of drug-metabolizing enzymes and transporters under diabetic conditions: what is the potential clinical significance?

  2018cites this paper
• Evaluating the impact of type 2 diabetes mellitus on CYP450 metabolic activities: protocol for a case–control pharmacokinetic study

  2018cites this paper
• Highly Sensitive LC-MS/MS-ESI method Development for the Determination of 5,7-dihydroxyflavone in Mouse Plasma and Pharmacokinetic Study in Lean and Diet Induced Obese Mice

  2018cites this paper
• Effects of Honokiol on CYP450 Activity and Transporter mRNA Expression in Type 2 Diabetic Rats

  2018cites this paper
• Pharmacogenetics of Ketamine-Induced Emergence Phenomena: A Pilot Study

  2017cites this paper
• Tissue Specific Modulation of cyp2c and cyp3a mRNA Levels and Activities by Diet-Induced Obesity in Mice: The Impact of Type 2 Diabetes on Drug Metabolizing Enzymes in Liver and Extra-Hepatic Tissues

  2017cites this paper
• Perspective: 4β-hydroxycholesterol as an emerging endogenous biomarker of hepatic CYP3A

  2017cites this paper
• The Cytoprotective Role of Cytochrome P450 2A5 against Oxidative Stress in Mouse Liver

  2017cites this paper
• Mise en évidence des effets du génotype, de l'agressivité et de l'hygiène sur la teneur en composés odorants du gras dorsal de la viande de porc mâle entier

  2016cites this paper
• A Pilot Study of the Pharmacogenetics of Ketamine-Induced Emergence Phenomena: A Dissertation

  2016cites this paper
• Evaluation of a New Molecular Entity as a Victim of Metabolic Drug-Drug Interactions—an Industry Perspective

  2016cites this paper
• Pharmacokinetics and Differential Regulation of Cytochrome P450 Enzymes in Type 1 Allergic Mice

  2016cites this paper
• Pharmacokinetic drug interactions in liver disease: An update.

  2016cites this paper
• Turpentine oil induced inflammation decreases absorption and increases distribution of phenacetin without altering its elimination process in rats

  2015cites this paper
• Inflammation-Induced Phenoconversion of Polymorphic Drug Metabolizing Enzymes: Hypothesis with Implications for Personalized Medicine

  2015cites this paper
• Mechanisms of lower maintenance dose of tacrolimus in obese patients.

  2014cites this paper
• Modulation of CYP3a expression and activity in mice models of type 1 and type 2 diabetes

  2014cites this paper
• Therapeutic drug monitoring in a developing nation: a clinical guide

  2014cites this paper
• Clinical uses of 1-alpha-hydroxycholecalciferol.

  2014cites this paper
• Consequences of psychophysiological stress on cytochrome P450-catalyzed drug metabolism.

  2014cites this paper
• Role of Constitutive Androstane Receptor in Toll-Like Receptor-Mediated Regulation of Gene Expression of Hepatic Drug-Metabolizing Enzymes and Transporters

  2014cites this paper
• Concentration of tacrolimus and major metabolites in kidney transplant recipients as a function of diabetes mellitus and cytochrome P450 3A gene polymorphism

  2013cites this paper
• Farmakokinetisk betydning av sekvensvarianter i CYP3A4, CYP3A5, POR og PPARA

  2013cites this paper
• Genetic polymorphisms of CYP2E1, GST, and NAT2 enzymes are not associated with risk of breast cancer in a sample of Lebanese women.

  2013cites this paper
• Impact of OATP1B1, MDR1, and CYP3A4 Expression in Liver and Intestine on Interpatient Pharmacokinetic Variability of Atorvastatin in Obese Subjects

  2013cites this paper
• Study of the pharmacokinetic changes of Tramadol in diabetic rats

  2013cites this paper
• Psychophysiological stress: a significant parameter in drug pharmacokinetics

  2013cites this paper
• Prevalence and predictors of potential drug-drug interactions in the elderly: a cross-sectional study in the brazilian primary public health system.

  2012cites this paper
• Effect of Diabetes Mellitus on Pharmacokinetic and Pharmacodynamic Properties of Drugs

  2012cites this paper
• Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression.

  2012cites this paper
• The fetal programming of dietary fructose and saturated fat on hepatic quercetin glucuronidation in rats

  2012cites this paper
• Elevated fat skatole levels in immunocastrated, surgically castrated and entire male pigs with acute dysentery.

  2012cites this paper
• Effect of Diabetes Mellitus on Pharmacokinetic and Pharmacodynamic Properties of Drugs

  2012cites this paper
• Transcriptional Regulation of Human Drug‐Metabolizing Cytochrome P450 Enzymes

  2012cites this paper
• Le cochon d'Inde comme modèle animal de biotransformation des médicaments : caractérisation de la sous-famille des cytochromes P450 2C, du transporteur membranaire MDR1 et des récepteurs nucléaires CAR et PXR

  2012cites this paper
• Effect of the ethinylestradiol/levonorgestrel combined oral contraceptive on the activity of cytochrome P4503A in obese women.

  2012cites this paper
• Influence of CYP2C9 and VKORC1 Polymorphisms on Warfarin and Acenocoumarol in a Sample of Lebanese People

  2011cites this paper
• Steroid regulation of drug-metabolizing cytochromes P450.

  2011cites this paper
• Antifungal Dosing in Obesity: A Review of the Literature

  2011cites this paper
• Cytochrome P450 (CYP) Gene Superfamily

  2011cites this paper
• In vivo effects of Faizol Ubat Batuk, a herbal product on aminopyrine metabolism in rat hepatocytes

  2011cites this paper
• Psychotropes et sujet âgé

  2011cites this paper
• Role of retinoids, rexinoids and thyroid hormone in the expression of cytochrome p450 enzymes.

  2011cites this paper
• Cytochrome P4502E1 (CYP2E1) Genetic Polymorphisms in a Lebanese Population: Frequency Distribution and Association with Morbid Diseases

  2010cites this paper
• Reciprocal Modulation of Hepatic Cytochrome P450 Gene Expressions with Streptozotocin Induced Diabetes and Resveratrol

  2010cites this paper
• The effect of broccoli in diet on the cytochrome P450 activities of tilapia fish (Oreochromis niloticus) during phenol exposure.

  2010cites this paper
• The effect of liver disease on inhibitory and plasma protein-binding displacement interactions: an update

  2010cites this paper
• Influence of Overt Diabetes Mellitus on Cyclosporine Pharmacokinetics in a Canine Model

  2009cites this paper
• Effect of obesity on serum amiodarone concentration in Japanese patients: population pharmacokinetic investigation by multiple trough screen analysis

  2009cites this paper
• Irreversible CYP3A Inhibition Accompanied by Plasma Protein–Binding Displacement: A Comparative Analysis in Subjects With Normal and Impaired Liver Function

  2009cites this paper
• Therapeutic product disposition in at-risk populations.

  2009cites this paper
• The role of hepatic cytochrome P-450 in sepsis.

  2009cites this paper
• Constitutive androstane receptor mediates the induction of drug metabolism in mouse models of type 1 diabetes

  2009cites this paper
• Use of Drugs that Act on the Cytochrome P450 System in the Elderly

  2009cites this paper
• Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trial

  2008cites this paper
• Blood and Plasma Pharmacokinetics of Ciclosporin in Diabetic Kidney Transplant Recipients

  2008cites this paper
• Pharmacokinetics of lidocaine and its metabolite in peridural anesthesia administered to pregnant women with gestational diabetes mellitus

  2008cites this paper
• Enzyme inhibition and induction in liver disease.

  2008cites this paper
• Long-Term Therapeutic Drug Monitoring of Risperidone and Olanzapine Identifies Altered Steady-State Pharmacokinetics

  2008cites this paper
• Focus on the intermediate state: immature mRNA of cytochromes P450—methods and insights

  2008cites this paper
• Research Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled

  2008cites this paper
• Estudo farmacocinético e análise da distribuição transplacentária da lidocaína e seu metabólito na assistência anestésica via peridural de gestantes diabéticas gestacionais

  2008cites this paper
• Introduction to Therapeutic Drug Monitoring

  2008cites this paper
• Identifizierung potentieller Interaktionspartner der Adiponectin Rezeptoren und Untersuchungen zur Adiponectin-induzierten Genexpression in Hepatozyten

  2008cites this paper
• Effect of Diabetes Mellitus on Mycophenolate Sodium Pharmacokinetics and Inosine Monophosphate Dehydrogenase Activity in Stable Kidney Transplant Recipients

  2007cites this paper
• Roles of the cytochrome P450 arachidonic acid monooxygenases in the control of systemic blood pressure and experimental hypertension.

  2007cites this paper
• Regulation of ion transport and blood pressure by cytochrome p450 monooxygenases

  2007cites this paper
• Molecular mechanisms of cytochrome p450 induction: potential for drug-drug interactions.

  2007cites this paper
• Antidiabetic and Long-term Effects of Elaeocarpus grandiflorus

  2007cites this paper
• Cytochrome P450: another player in the myocardial infarction game?

  2007cites this paper
• El citocromo P-450 y la respuesta terapéutica a los antimaláricos

  2006cites this paper
• Changes in the expression of cytochromes P450 and nuclear receptors in the liver of genetically diabetic db/db mice.

  2006cites this paper
• MODULATION OF CYP1A2 AND CYP3A6 CATALYTIC ACTIVITIES BY SERUM FROM RABBITS WITH A TURPENTINE-INDUCED INFLAMMATORY REACTION AND INTERLEUKIN 6

  2006cites this paper
• Lidocaine metabolism in isolated perfused liver from streptozotocin‐induced diabetic rats

  2006cites this paper
• Hepatic CYP3A Expression is Attenuated in Obese Mice Fed a High-Fat Diet

  2006cites this paper
• [Cytochrome P-450 and the response to antimalarial drugs].

  2006cites this paper
• Use of a Physiologically Based Pharmacokinetic Model for Rats to Study the Influence of Body Fat Mass and Induction of CYP1A2 on the Pharmacokinetics of TCDD

  2006cites this paper
• Relationship between in vivo chlorzoxazone hydroxylation, hepatic cytochrome P450 2E1 content and liver injury in obese non-alcoholic fatty liver disease patients.

  2006cites this paper
• Modulation of CYP 1 A 2 and CYP 3 A 6 catalytic activities by serum from rabbits with a turpentine-induced inflammatory reaction and IL-6

  2005cites this paper